Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to compare the length of time to achieve ovulation and pregnancy with a traditional protocol administration of clomiphene citrate versus a stair step administration.

Our hypothesis is by using a stair-step approach in which a period is not induced between administrations of escalating doses of clomiphene citrate, the time to ovulation and pregnancy may be reduced.


Clinical Trial Description

The traditional administration of clomiphene citrate for ovulation induction involves taking clomiphene citrate for 5 days. If ovulation does not occur within 14 days, a progestin pill (such as Provera) is prescribed for 10 days to induce a period (which normally occurs within 1 week of stopping the pill). Then a higher dose of clomiphene citrate will be prescribed.

The stair-step administration of clomiphene citrate for ovulation induction also involves taking clomiphene citrate for 5 days. In contrast, if ovulation does not occur within 7-9 days, a progestin pill (such as Provera) would NOT be taken to induce a period. The dose of clomiphene will then be increased. Therefore, this would do away with the 10 days of taking the progestin pill, and also do away with waiting for a period (usually 3 to 7 days) for a total of up to a 20 day difference between clomiphene citrate dosing cycles. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01008319
Study type Interventional
Source University of Oklahoma
Contact
Status Completed
Phase Phase 3
Start date October 2009
Completion date November 2015

See also
  Status Clinical Trial Phase
Completed NCT01653743 - Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women Phase 3
Completed NCT00327366 - Effect of Bright Light on Sex Hormones and Ovulation in Humans N/A
Not yet recruiting NCT02551367 - Letrozole Versus Clomiphene Citrate for Ovulation Induction in Women With Poly Cystic Ovary Syndrome ( PCOS ) Phase 2
Completed NCT01923194 - Evaluation of Efficacy and Safety of Highly Purified Urofollitropin for Ovulation Induction in Chinese Females Phase 3
Completed NCT00239603 - Efficacy Study of the OV-Watchâ„¢ Personal Fertility Monitor for Women Using Clomiphene Citrate. Phase 4
Recruiting NCT02309047 - The Cycle Disturbances, OLigomenorrhea and Amenorrhea (COLA) Study & Biobank
Completed NCT03252223 - Ovarian Response to Recombinant Follicle Stimulating Hormone in Women With PCOS Phase 4
Completed NCT00492882 - Study of Mechanisms of Anovulation in Polycystic Ovary Syndrome Phase 4
Completed NCT02335879 - Phase III Clinical Study of Domestic Recombinant Human Follitropin for Injection to Treat WHO Class II Anovulation Phase 3
Completed NCT00471523 - Treatment of Anovulatory Infertility in PCOS Patients Phase 4
Completed NCT02703649 - Administration of Single High Dose Letrozole for Ovulation Induction Phase 4
Completed NCT00213148 - Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction Phase 2
Completed NCT03018314 - Serum Kisspeptin Levels in Infertile Women N/A
Completed NCT02710981 - Sildenafil Vaginal Gel Co-treatment With Clomiphene Citrate in Infertile Women With Thin Endometrium N/A
Recruiting NCT02186782 - Concomitant CC and E2 Versus CC Alone in Ovulation Induction Phase 4
Not yet recruiting NCT00665171 - Whole Genome Analysis for the Detection of Key Genes in the Polycystic Ovary Syndrome N/A
Withdrawn NCT03155828 - Using CPAP to Improve Menstruation in Women With Polycystic Ovarian Syndrome and Obstructive Sleep Apnea
Withdrawn NCT00453219 - FHA: Characterization of Metabolic Status, Brain Circuitry, and Stress-Reactivity N/A
Completed NCT00920634 - Protocol for Drug Use Investigation of Follistim Injection (Study P06132)(COMPLETED)
Recruiting NCT06208995 - Quality of Life in Normogonadotropic Anovulation